Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

Global impact of rotavirus vaccine introduction on rotavirus hospitalisations among children under 5 years of age, 2008-16: findings from the Global Rotavirus Surveillance Network.

Aliabadi N, Antoni S, Mwenda JM, Weldegebriel G, Biey JNM, Cheikh D, Fahmy K, Teleb N, Ashmony HA, Ahmed H, Daniels DS, Videbaek D, Wasley A, Singh S, de Oliveira LH, Rey-Benito G, Sanwogou NJ, Wijesinghe PR, Liyanage JBL, Nyambat B, Grabovac V, Heffelfinger JD, Fox K, Paladin FJ, Nakamura T, Agócs M, Murray J, Cherian T, Yen C, Parashar UD, Serhan F, Tate JE, Cohen AL.

Lancet Glob Health. 2019 Jul;7(7):e893-e903. doi: 10.1016/S2214-109X(19)30207-4.

2.

Evidence of reduction of rotavirus diarrheal disease after rotavirus vaccine introduction in national immunization programs in the African countries: Report of the 11th African rotavirus symposium held in Lilongwe, Malawi.

Mwenda JM, Mandomando I, Jere KC, Cunliffe NA, Duncan Steele A.

Vaccine. 2019 May 21;37(23):2975-2981. doi: 10.1016/j.vaccine.2019.03.047. Epub 2019 Apr 24.

PMID:
31029514
3.

Analysis of Death and Survival Factors Associated with Childhood Bacterial Meningitis at a Reference Pediatric Hospital in Antananarivo, Madagascar.

Mioramalala SA, Ramasy Razafindratovo RM, Rakotozanany A, Miarimbola R, Weldegebriel G, Mwenda JM, Robinson AL.

J Immunol Sci. 2018 Jul 2;Suppl(2):8-14.

4.

Rates of hospitalization and death for all-cause and rotavirus acute gastroenteritis before rotavirus vaccine introduction in Kenya, 2010-2013.

Omore R, Khagayi S, Ogwel B, Onkoba R, Ochieng JB, Juma J, Munga S, Tabu C, Kibet S, Nuorti JP, Odhiambo F, Mwenda JM, Breiman RF, Parashar UD, Tate JE.

BMC Infect Dis. 2019 Jan 11;19(1):47. doi: 10.1186/s12879-018-3615-6.

5.

Monovalent rotavirus vaccine effectiveness against rotavirus hospitalizations among children in Zimbabwe.

Mujuru HA, Burnett E, Nathoo KJ, Ticklay I, Gonah NA, Mukaratirwa A, Berejena C, Manangazira P, Rupfutse M, Weldegebriel GG, Mwenda JM, Yen C, Parashar UD, Tate JE.

Clin Infect Dis. 2018 Dec 23. doi: 10.1093/cid/ciy1096. [Epub ahead of print]

PMID:
30590488
6.

Impact of rotavirus vaccine introduction and genotypic characteristics of rotavirus strains in children less than 5 years of age with gastroenteritis in Ethiopia: 2011-2016.

Abebe A, Getahun M, Mapaseka SL, Beyene B, Assefa E, Teshome B, Tefera M, Kebede F, Habtamu A, Haile-Mariam T, Jeffrey Mphahlele M, Teshager F, Ademe A, Teka T, Weldegebriel GG, Mwenda JM.

Vaccine. 2018 Nov 12;36(46):7043-7047. doi: 10.1016/j.vaccine.2018.09.048. Epub 2018 Oct 6.

PMID:
30301641
7.

Intussusception after Rotavirus Vaccination in Africa.

Tate JE, Mwenda JM, Parashar UD.

N Engl J Med. 2018 Sep 27;379(13):1288-1289. doi: 10.1056/NEJMc1807645. No abstract available.

PMID:
30257154
8.

Meningococcus serogroup C clonal complex ST-10217 outbreak in Zamfara State, Northern Nigeria.

Kwambana-Adams BA, Amaza RC, Okoi C, Rabiu M, Worwui A, Foster-Nyarko E, Ebruke B, Sesay AK, Senghore M, Umar AS, Usman R, Atiku A, Abdullahi G, Buhari Y, Sani R, Bako HU, Abdullahi B, Yarima AI, Sikiru B, Moses AO, Popoola MO, Ekeng E, Olayinka A, Mba N, Kankia A, Mamadu IN, Okudo I, Stephen M, Ronveaux O, Busuttil J, Mwenda JM, Abdulaziz M, Gummi SA, Adedeji A, Bita A, Omar L, Djingarey MH, Alemu W, D'Alessandro U, Ihekweazu C, Antonio M.

Sci Rep. 2018 Sep 21;8(1):14194. doi: 10.1038/s41598-018-32475-2.

9.

Rotavirus Vaccination and the Global Burden of Rotavirus Diarrhea Among Children Younger Than 5 Years.

Troeger C, Khalil IA, Rao PC, Cao S, Blacker BF, Ahmed T, Armah G, Bines JE, Brewer TG, Colombara DV, Kang G, Kirkpatrick BD, Kirkwood CD, Mwenda JM, Parashar UD, Petri WA Jr, Riddle MS, Steele AD, Thompson RL, Walson JL, Sanders JW, Mokdad AH, Murray CJL, Hay SI, Reiner RC Jr.

JAMA Pediatr. 2018 Oct 1;172(10):958-965. doi: 10.1001/jamapediatrics.2018.1960.

10.

Using pneumococcal and rotavirus surveillance in vaccine decision-making: A series of case studies in Bangladesh, Armenia and the Gambia.

Hasan AZ, Saha S, Saha SK, Sahakyan G, Grigoryan S, Mwenda JM, Antonio M, Knoll MD, Serhan F, Cohen AL; Pneumococcal and rotavirus surveillance case study group.

Vaccine. 2018 Aug 6;36(32 Pt B):4939-4943. doi: 10.1016/j.vaccine.2018.06.001. Epub 2018 Jun 29.

PMID:
30037484
11.

Impact of rotavirus vaccines in Sub-Saharan African countries.

Mwenda JM, Parashar UD, Cohen AL, Tate JE.

Vaccine. 2018 Nov 12;36(47):7119-7123. doi: 10.1016/j.vaccine.2018.06.026. Epub 2018 Jun 18.

PMID:
29914848
12.

Diversity of rotavirus strains circulating in children under five years of age who presented with acute gastroenteritis before and after rotavirus vaccine introduction, University Teaching Hospital, Lusaka, Zambia, 2008-2015.

Simwaka JC, Mpabalwani EM, Seheri M, Peenze I, Monze M, Matapo B, Parashar UD, Mufunda J, Mphahlele JM, Tate JE, Mwenda JM.

Vaccine. 2018 Nov 12;36(47):7243-7247. doi: 10.1016/j.vaccine.2018.03.035. Epub 2018 Jun 12.

PMID:
29907481
13.

Rotavirus diarrhoea hospitalizations among children under 5 years of age in Nigeria, 2011-2016.

Tagbo BN, Mwenda JM, Eke CB, Edelu BO, Chukwubuike C, Armah G, Seheri ML, Isiaka A, Namadi L, Okafor HU, Ozumba UC, Nnani RO, Okafor V, Njoku R, Odume C, Benjamin-Pujah C, Azubuike C, Umezinne N, Ogude N, Osarogborun VO, Okwesili MU, Ezebilo SK, Udemba O, Yusuf K, Mahmud Z, Ticha JM, Obidike EO, Mphahlele JM; ICH UNTH Enugu Rotavirus Group.

Vaccine. 2018 Dec 14;36(51):7759-7764. doi: 10.1016/j.vaccine.2018.03.084. Epub 2018 May 22.

PMID:
29802002
14.

Sustained impact of rotavirus vaccine on rotavirus hospitalisations in Lusaka, Zambia, 2009-2016.

Mpabalwani EM, Simwaka JC, Mwenda JM, Matapo B, Parashar UD, Tate JE.

Vaccine. 2018 Nov 12;36(47):7165-7169. doi: 10.1016/j.vaccine.2018.02.077. Epub 2018 May 21.

PMID:
29793891
15.

Whole-genome sequencing and analyses identify high genetic heterogeneity, diversity and endemicity of rotavirus genotype P[6] strains circulating in Africa.

Nyaga MM, Tan Y, Seheri ML, Halpin RA, Akopov A, Stucker KM, Fedorova NB, Shrivastava S, Duncan Steele A, Mwenda JM, Pickett BE, Das SR, Jeffrey Mphahlele M.

Infect Genet Evol. 2018 Sep;63:79-88. doi: 10.1016/j.meegid.2018.05.013. Epub 2018 May 18.

16.

Impact of routine rotavirus vaccination on all-cause and rotavirus hospitalizations during the first four years following vaccine introduction in Rwanda.

Sibomana H, Rugambwa C, Mwenda JM, Sayinzoga F, Iraguha G, Uwimana J, Parashar UD, Tate JE.

Vaccine. 2018 Nov 12;36(47):7135-7141. doi: 10.1016/j.vaccine.2018.01.072. Epub 2018 May 10.

PMID:
29754701
17.

Sustained impact of rotavirus vaccine introduction on rotavirus gastroenteritis hospitalizations in children <5 years of age, Ghana, 2009-2016.

Enweronu-Laryea CC, Armah G, Sagoe KW, Ansong D, Addo-Yobo E, Diamenu SK, Mwenda JM, Parashar UD, Tate JE.

Vaccine. 2018 Nov 12;36(47):7131-7134. doi: 10.1016/j.vaccine.2018.02.058. Epub 2018 May 8.

PMID:
29752020
18.

Evaluation of Intussusception after Monovalent Rotavirus Vaccination in Africa.

Tate JE, Mwenda JM, Armah G, Jani B, Omore R, Ademe A, Mujuru H, Mpabalwani E, Ngwira B, Cortese MM, Mihigo R, Glover-Addy H, Mbaga M, Osawa F, Tadesse A, Mbuwayesango B, Simwaka J, Cunliffe N, Lopman BA, Weldegebriel G, Ansong D, Msuya D, Ogwel B, Karengera T, Manangazira P, Bvulani B, Yen C, Zawaira FR, Narh CT, Mboma L, Saula P, Teshager F, Getachew H, Moeti RM, Eweronu-Laryea C, Parashar UD; African Intussusception Surveillance Network.

N Engl J Med. 2018 Apr 19;378(16):1521-1528. doi: 10.1056/NEJMoa1713909.

19.

Detection of rotavirus before and after monovalent rotavirus vaccine introduction and vaccine effectiveness among children in mainland Tanzania.

Jani B, Hokororo A, Mchomvu J, Cortese MM, Kamugisha C, Mujuni D, Kallovya D, Parashar UD, Mwenda JM, Lyimo D; Tanzania Rotavirus Surveillance Teams, Materu A, Omari KF, Waziri M, Laswai T, Juma H, Mlay J, Dogani J, Stephen E, Seugendo M, Nkumbi U, Lyakurwa A, Matojo A, Bendera E, Senyota J, Msingwa V, Fungo Y, Michael F, Mpamba A, Chambo A, Cholobi H, Lyamuya F, Chami I, Mchome E, Mshana AM, Mushi E, Mariki U, Chard R, Tuju D, Ambokile N, Lukwale F, Kyessi F, Khamis A, Michael I, Macha D, Saguti A.

Vaccine. 2018 Nov 12;36(47):7149-7156. doi: 10.1016/j.vaccine.2018.01.071. Epub 2018 Apr 11.

PMID:
29655631
20.

Trends in diarrhea hospitalizations among infants at three hospitals in Tanzania before and after rotavirus vaccine introduction.

Lyamuya F, Michael F, Jani B, Fungo Y, Chambo A, Chami I, Bulali R, Mpamba A, Cholobi H, Kallovya D, Kamugisha C, Mwenda JM, Cortese MM.

Vaccine. 2018 Nov 12;36(47):7157-7164. doi: 10.1016/j.vaccine.2017.11.051. Epub 2018 Apr 11.

PMID:
29655628
21.

Distribution of rotavirus genotypes associated with acute diarrhoea in Zimbabwean children less than five years old before and after rotavirus vaccine introduction.

Mukaratirwa A, Berejena C, Nziramasanga P, Ticklay I, Gonah A, Nathoo K, Manangazira P, Mangwanya D, Marembo J, Mwenda JM, Weldegebriel G, Seheri M, Tate JE, Yen C, Parashar U, Mujuru H.

Vaccine. 2018 Nov 12;36(47):7248-7255. doi: 10.1016/j.vaccine.2018.03.069. Epub 2018 Apr 5.

PMID:
29628149
22.

Impact of pentavalent rotavirus vaccine against severe rotavirus diarrhoea in The Gambia.

Sanneh B, Papa Sey A, Shah M, Tate J, Sonko M, Jagne S, Jarju M, Sowe D, Taal M, Cohen A, Parashar U, Mwenda JM.

Vaccine. 2018 Nov 12;36(47):7179-7184. doi: 10.1016/j.vaccine.2018.02.091. Epub 2018 Mar 12.

PMID:
29544688
23.

Evidence of the impact of monovalent rotavirus vaccine on childhood acute gastroenteritis hospitalization in Togo.

Tsolenyanu E, Djadou KE, Fiawoo M, Akolly DAE, Mwenda JM, Leshem E, Tate JE, Aliabadi N, Koudema W, Guedenon KM, Godonou M, Dagnra A, Gbadoe AD, Boko A, Landoh D, Atakouma Y, Parashar UD.

Vaccine. 2018 Nov 12;36(47):7185-7191. doi: 10.1016/j.vaccine.2018.01.058. Epub 2018 Feb 1.

PMID:
29397224
24.

Rotavirus strain distribution in Ghana pre- and post- rotavirus vaccine introduction.

Lartey BL, Damanka S, Dennis FE, Enweronu-Laryea CC, Addo-Yobo E, Ansong D, Kwarteng-Owusu S, Sagoe KW, Mwenda JM, Diamenu SK, Narh C, Binka F, Parashar U, Lopman B, Armah GE.

Vaccine. 2018 Nov 12;36(47):7238-7242. doi: 10.1016/j.vaccine.2018.01.010. Epub 2018 Jan 20.

PMID:
29371014
25.

Emergence of G12 and G9 rotavirus genotypes in the Central African Republic, January 2014 to February 2016.

Moure UAE, Banga-Mingo V, Gody JC, Mwenda JM, Fandema J, Waku-Kouomou D, Manengu C, Koyazegbe TD, Esona MD, Bowen MD, Gouandijka-Vasilache I.

BMC Res Notes. 2018 Jan 5;11(1):5. doi: 10.1186/s13104-017-3122-7.

26.

Impact and effectiveness of pentavalent rotavirus vaccine in children <5 years of age in Burkina Faso.

Bonkoungou IJO, Aliabadi N, Leshem E, Kam M, Nezien D, Drabo MK, Nikiema M, Ouedraogo B, Medah I, Konaté S, Ouédraogo-Traoré R, Sangaré L, Kam L, Yé D, Ouattara M, Biey JN, Mwenda JM, Tate JE, Parashar UD.

Vaccine. 2018 Nov 12;36(47):7170-7178. doi: 10.1016/j.vaccine.2017.12.056. Epub 2017 Dec 28.

PMID:
29290478
27.

Rotavirus strain diversity in Eastern and Southern African countries before and after vaccine introduction.

Seheri LM, Magagula NB, Peenze I, Rakau K, Ndadza A, Mwenda JM, Weldegebriel G, Steele AD, Mphahlele MJ.

Vaccine. 2018 Nov 12;36(47):7222-7230. doi: 10.1016/j.vaccine.2017.11.068. Epub 2017 Dec 2.

PMID:
29203181
28.

Impact of rotavirus vaccine on acute gastroenteritis in children under 5 years in Senegal: Experience of sentinel site of the Albert Royer Children's Hospital in Dakar.

Diop A, Thiongane A, Mwenda JM, Aliabadi N, Sonko MA, Diallo A, Ndoye B, Faye PM, Ba ID, Parashar UD, Tate JE, Ndiaye O, Cissé MF, Ba M.

Vaccine. 2018 Nov 12;36(47):7192-7197. doi: 10.1016/j.vaccine.2017.10.061. Epub 2017 Nov 20.

PMID:
29162319
29.

Early impact of rotavirus vaccination in children less than five years of age in Mozambique.

de Deus N, Chilaúle JJ, Cassocera M, Bambo M, Langa JS, Sitoe E, Chissaque A, Anapakala E, Sambo J, Guimarães EL, Bero DM, João ED, Cossa-Moiane I, Mwenda JM, Weldegebriel GG, Parashar UD, Tate JE.

Vaccine. 2018 Nov 12;36(47):7205-7209. doi: 10.1016/j.vaccine.2017.10.060. Epub 2017 Nov 8.

PMID:
29128381
30.

Impact of rotavirus vaccine on rotavirus diarrhoea in countries of East and Southern Africa.

Weldegebriel G, Mwenda JM, Chakauya J, Daniel F, Masresha B, Parashar UD, Tate JE.

Vaccine. 2018 Nov 12;36(47):7124-7130. doi: 10.1016/j.vaccine.2017.10.050. Epub 2017 Nov 6.

PMID:
29102168
31.

Implementation of Rotavirus Surveillance and Vaccine Introduction - World Health Organization African Region, 2007-2016.

Mwenda JM, Burke RM, Shaba K, Mihigo R, Tevi-Benissan MC, Mumba M, Biey JN, Cheikh D, Poy MSc A, Zawaira FR, Aliabadi N, Tate JE, Hyde T, Cohen AL, Parashar UD.

MMWR Morb Mortal Wkly Rep. 2017 Nov 3;66(43):1192-1196. doi: 10.15585/mmwr.mm6643a7.

32.

Impact of rotavirus vaccine on all-cause diarrhea and rotavirus hospitalizations in Madagascar.

Rahajamanana VL, Raboba JL, Rakotozanany A, Razafindraibe NJ, Andriatahirintsoa EJPR, Razafindrakoto AC, Mioramalala SA, Razaiarimanga C, Weldegebriel GG, Burnett E, Mwenda JM, Seheri M, Mphahlele MJ, Robinson AL.

Vaccine. 2018 Nov 12;36(47):7198-7204. doi: 10.1016/j.vaccine.2017.08.091. Epub 2017 Sep 25.

PMID:
28958809
33.

Reaching every child with rotavirus vaccine: Report from the 10th African rotavirus symposium held in Bamako, Mali.

Sow SO, Steele AD, Mwenda JM, Armah GE, Neuzil KM.

Vaccine. 2017 Oct 9;35(42):5511-5518. doi: 10.1016/j.vaccine.2017.08.084.

34.

Etiology of Severe Acute Watery Diarrhea in Children in the Global Rotavirus Surveillance Network Using Quantitative Polymerase Chain Reaction.

Operario DJ, Platts-Mills JA, Nadan S, Page N, Seheri M, Mphahlele J, Praharaj I, Kang G, Araujo IT, Leite JPG, Cowley D, Thomas S, Kirkwood CD, Dennis F, Armah G, Mwenda JM, Wijesinghe PR, Rey G, Grabovac V, Berejena C, Simwaka CJ, Uwimana J, Sherchand JB, Thu HM, Galagoda G, Bonkoungou IJO, Jagne S, Tsolenyanu E, Diop A, Enweronu-Laryea C, Borbor SA, Liu J, McMurry T, Lopman B, Parashar U, Gentsch J, Steele AD, Cohen A, Serhan F, Houpt ER.

J Infect Dis. 2017 Jul 15;216(2):220-227. doi: 10.1093/infdis/jix294. Erratum in: J Infect Dis. 2017 Nov 15;216(8):1048.

35.

Estimated reductions in hospitalizations and deaths from childhood diarrhea following implementation of rotavirus vaccination in Africa.

Shah MP, Tate JE, Mwenda JM, Steele AD, Parashar UD.

Expert Rev Vaccines. 2017 Oct;16(10):987-995. doi: 10.1080/14760584.2017.1371595. Epub 2017 Sep 4. Review.

PMID:
28832219
36.

Early impact of rotavirus vaccine in under 5year old children hospitalized due to diarrhea, Swaziland.

Maphalala G, Phungwayo N, Masona G, Lukhele N, Tsegaye G, Dube N, Sindisiwe D, Khumalo L, Daniel F, Katsande R, Tate JE, Mwenda JM, Weldegebriel G.

Vaccine. 2018 Nov 12;36(47):7210-7214. doi: 10.1016/j.vaccine.2017.07.072. Epub 2017 Aug 1.

PMID:
28778615
37.

Reduction in Diarrhea- and Rotavirus-related Healthcare Visits Among Children <5 Years of Age After National Rotavirus Vaccine Introduction in Zimbabwe.

Mujuru HA, Yen C, Nathoo KJ, Gonah NA, Ticklay I, Mukaratirwa A, Berejena C, Tapfumanei O, Chindedza K, Rupfutse M, Weldegebriel G, Mwenda JM, Burnett E, Tate JE, Parashar UD, Manangazira P.

Pediatr Infect Dis J. 2017 Oct;36(10):995-999. doi: 10.1097/INF.0000000000001648.

38.

Feasibility of using regional sentinel surveillance to monitor the rotavirus vaccine impact, effectiveness and intussusception incidence in the African Region.

Mandomando I, Weldegebriel G, de Deus N, Mwenda JM.

Vaccine. 2017 Mar 23;35(13):1663-1667. doi: 10.1016/j.vaccine.2017.01.072. Epub 2017 Mar 1.

PMID:
28242070
39.

Monovalent Rotavirus Vaccine Effectiveness and Impact on Rotavirus Hospitalizations in Zanzibar, Tanzania: Data From the First 3 Years After Introduction.

Abeid KA, Jani B, Cortese MM, Kamugisha C, Mwenda JM, Pandu AS, Msaada KA, Mohamed AS, Khamis AU, Parashar UD, Saleh AA.

J Infect Dis. 2017 Jan 15;215(2):183-191. doi: 10.1093/infdis/jiw524.

PMID:
27815381
40.

An outbreak of pneumococcal meningitis among older children (≥5 years) and adults after the implementation of an infant vaccination programme with the 13-valent pneumococcal conjugate vaccine in Ghana.

Kwambana-Adams BA, Asiedu-Bekoe F, Sarkodie B, Afreh OK, Kuma GK, Owusu-Okyere G, Foster-Nyarko E, Ohene SA, Okot C, Worwui AK, Okoi C, Senghore M, Otu JK, Ebruke C, Bannerman R, Amponsa-Achiano K, Opare D, Kay G, Letsa T, Kaluwa O, Appiah-Denkyira E, Bampoe V, Zaman SM, Pallen MJ, D'Alessandro U, Mwenda JM, Antonio M.

BMC Infect Dis. 2016 Oct 18;16(1):575.

41.

Review of Naturally Occurring Intussusception in Young Children in the WHO African Region prior to the Era of Rotavirus Vaccine Utilization in the Expanded Programme of Immunization.

Mpabalwani EM, Mwenda JM, Tate JE, Parashar UD.

J Trop Pediatr. 2017 Jun 1;63(3):221-228. doi: 10.1093/tropej/fmw069.

PMID:
27694631
42.

Effectiveness of Pentavalent Rotavirus Vaccine Under Conditions of Routine Use in Rwanda.

Tate JE, Ngabo F, Donnen P, Gatera M, Uwimana J, Rugambwa C, Mwenda JM, Parashar UD.

Clin Infect Dis. 2016 May 1;62 Suppl 2:S208-12. doi: 10.1093/cid/civ1016.

PMID:
27059358
43.

Impact and Effectiveness of Monovalent Rotavirus Vaccine Against Severe Rotavirus Diarrhea in Ghana.

Armah G, Pringle K, Enweronu-Laryea CC, Ansong D, Mwenda JM, Diamenu SK, Narh C, Lartey B, Binka F, Grytdal S, Patel M, Parashar U, Lopman B.

Clin Infect Dis. 2016 May 1;62 Suppl 2:S200-7. doi: 10.1093/cid/ciw014.

PMID:
27059357
44.

Early Evidence of Impact of Monovalent Rotavirus Vaccine in Togo.

Tsolenyanu E, Mwenda JM, Dagnra A, Leshem E, Godonou M, Nassoury I, Landoh D, Tate JE, Atakouma Y, Parashar UD.

Clin Infect Dis. 2016 May 1;62 Suppl 2:S196-9. doi: 10.1093/cid/civ1182.

PMID:
27059356
45.

Impact of Rotavirus Vaccination on Diarrheal Hospitalizations in Children Aged <5 Years in Lusaka, Zambia.

Mpabalwani EM, Simwaka CJ, Mwenda JM, Mubanga CP, Monze M, Matapo B, Parashar UD, Tate JE.

Clin Infect Dis. 2016 May 1;62 Suppl 2:S183-7. doi: 10.1093/cid/civ1027.

PMID:
27059354
46.

The Economic Burden Attributable to a Child's Inpatient Admission for Diarrheal Disease in Rwanda.

Ngabo F, Mvundura M, Gazley L, Gatera M, Rugambwa C, Kayonga E, Tuyishime Y, Niyibaho J, Mwenda JM, Donnen P, Lepage P, Binagwaho A, Atherly D.

PLoS One. 2016 Feb 22;11(2):e0149805. doi: 10.1371/journal.pone.0149805. eCollection 2016.

47.

Effect of pentavalent rotavirus vaccine introduction on hospital admissions for diarrhoea and rotavirus in children in Rwanda: a time-series analysis.

Ngabo F, Tate JE, Gatera M, Rugambwa C, Donnen P, Lepage P, Mwenda JM, Binagwaho A, Parashar UD.

Lancet Glob Health. 2016 Feb;4(2):e129-36. doi: 10.1016/S2214-109X(15)00270-3.

48.

c-Jun NH2-terminal kinase inhibitor bentamapimod reduces induced endometriosis in baboons: an assessor-blind placebo-controlled randomized study.

Hussein M, Chai DC, Kyama CM, Mwenda JM, Palmer SS, Gotteland JP, D'Hooghe TM.

Fertil Steril. 2016 Mar;105(3):815-824.e5. doi: 10.1016/j.fertnstert.2015.11.022. Epub 2015 Dec 2.

PMID:
26654972
49.

Strengthening laboratory capacity through the surveillance of rotavirus gastroenteritis in Central Africa: the Surveillance Épidémiologique en Afrique Centrale (SURVAC) Project.

Waku-Kouomou D, Esona MD, Pukuta E, Gouandijka-Vasilache I, Boula A, Dahl BA, Mondonge V, Mekontso D, Guifara G, Mbary-Daba R, Lewis J, Yahaya AA, Mwenda JM, Cavallaro KF, Gody JC, Muyembe JJ, Koki-Ndombo P, Bowen MD.

Trop Med Int Health. 2016 Jan;21(1):122-130. doi: 10.1111/tmi.12631. Epub 2015 Nov 16.

50.

Whole genome detection of rotavirus mixed infections in human, porcine and bovine samples co-infected with various rotavirus strains collected from sub-Saharan Africa.

Nyaga MM, Jere KC, Esona MD, Seheri ML, Stucker KM, Halpin RA, Akopov A, Stockwell TB, Peenze I, Diop A, Ndiaye K, Boula A, Maphalala G, Berejena C, Mwenda JM, Steele AD, Wentworth DE, Mphahlele MJ.

Infect Genet Evol. 2015 Apr;31:321-34. doi: 10.1016/j.meegid.2015.02.011. Epub 2015 Feb 17.

Supplemental Content

Loading ...
Support Center